查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物樣本庫市場報告：至2030年的趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356780

生物樣本庫市場報告：至2030年的趨勢、預測與競爭分析

Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物樣本庫趨勢與預測

預計到2030年，全球生物銀行市場將達到 61 億美元，2024年至2030年年複合成長率為 10.5%。該市場的主要驅動力是基因檢測和精準醫療需求的不斷成長、新生兒臍帶血幹細胞儲存的日益普及以及虛擬生物庫軟體的出現。全球生物樣本庫市場的未來充滿希望，為製藥和生物技術公司、CRO、學術和研究機構以及醫院市場提供了機會。

生物樣本庫市場洞察

Lucintel 預測，在預測期內，設備將經歷最高的成長。

預計亞太地區在預測期內將出現最高成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球生物樣本庫市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物樣本庫市場趨勢（2018-2023）與預測（2024-2030）
  • 按樣本類型分類的全球生物樣本庫市場
    • 血液製品
    • 人體組織
    • 細胞株
    • 核酸
    • 體液
    • 人類排泄物
  • 依產品和服務分類的全球生物樣本庫市場
    • 裝置
    • 消耗品
    • 服務
    • 軟體
  • 依應用分類的全球生物樣本庫市場
    • 再生醫學
    • 生命科學研究
    • 臨床調查
  • 全球生物樣本庫市場（依最終用途）
    • 製藥和生物技術公司以及 CRO
    • 學術研究所
    • 醫院

第4章 2018-2030年市場趨勢及預測分析（依地區）

  • 全球生物樣本庫市場（依地區）
  • 北美生物樣本庫市場
  • 歐洲生物樣本庫市場
  • 亞太生物樣本庫市場
  • 其他區域生物樣本庫市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球生物樣本庫市場成長機會（按樣本類型）
    • 全球生物樣本庫市場成長機會（依產品和服務）
    • 全球生物樣本庫市場成長機會（依應用）
    • 全球生物樣本庫市場成長機會（依最終用途）
    • 全球生物樣本庫市場成長機會（依地區）
  • 全球生物樣本庫市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物樣本庫市場的容量
    • 全球生物銀行市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • QIAGEN NV
  • Merck KGaA
  • Avantor
  • Cryoport
  • Tecan Trading
  • Azenta
簡介目錄

Biobanking Trends and Forecast

The future of the global biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets. The global biobanking market is expected to reach an estimated $xxx billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of chronic diseases.

A more than 150-page report is developed to help in your business decisions.

Biobanking by Segment

The study includes a forecast for the global biobanking by product & service, sample type, application, end use industry, and region.

Biobanking Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Equipment
  • Consumables
  • Software
  • Services

Biobanking Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood
  • Tissue
  • Nucleic Acids
  • Cell Lines

Biobanking Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutics
  • Drug Discovery & Clinical Research
  • Clinical Diagnostics
  • Other Applications

Biobanking Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies and Cros
  • Academic & Research Institutes
  • Hospitals

Biobanking Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biobanking Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biobanking companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking companies profiled in this report include-

  • Thermo Fisher Scientific
  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences

Biobanking Market Insights

Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Within this market, therapeutics will remain the largest segment due to the growing demand for advanced therapies for the treatment of chronic diseases.

North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Features of the Global Biobanking Market

Market Size Estimates: Biobanking market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biobanking market size by various segments, such as by product & service, sample type , application, end use industry, and region in terms of ($B).

Regional Analysis: Biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & service, sample types , applications, end use industries, and regions for the biobanking market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biobanking market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biobanking market size?

Answer: The global biobanking market is expected to reach an estimated $xxx billion by 2030.

Q.2 What is the growth forecast for biobanking market?

Answer: The global biobanking market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biobanking market?

Answer: The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of cronic diseases.

Q4. What are the major segments for biobanking market?

Answer: The future of the biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets.

Q5. Who are the key biobanking market companies?

Answer: Some of the key biobanking companies are as follows:

  • PHC Holdings
  • Becton
  • Dickinson and Company
  • Qiagen
  • Greiner Holding
  • Bay Biosciences
  • Bay Biosciences

Q6. Which biobanking market segment will be the largest in future?

Answer: Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Q7. In biobanking market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biobanking market by product & service (equipment, consumables, software, and services), sample type (blood, tissue, nucleic acids, and cell lines), application (therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications), end use industry (pharmaceutical & biotechnology companies and cros, academic & research institutes, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biobanking Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biobanking Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biobanking Market by Product & Service
    • 3.3.1: Equipment
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global Biobanking Market by Sample Type
    • 3.4.1: Blood
    • 3.4.2: Tissue
    • 3.4.3: Nucleic Acids
    • 3.4.4: Cell lines
  • 3.5: Global Biobanking Market by Application
    • 3.5.1: Therapeutics
    • 3.5.2: Drug Discovery & Clinical Research
    • 3.5.3: Clinical Diagnostics
    • 3.5.4: Other Applications
  • 3.6: Global Biobanking Market by End Use Industry
    • 3.6.1: Pharmaceutical & Biotechnology Companies and CROs
    • 3.6.2: Academic & Research Institutes
    • 3.6.3: Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biobanking Market by Region
  • 4.2: North American Biobanking Market
    • 4.2.2: North American Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.3: European Biobanking Market
    • 4.3.1: European Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.3.2: European Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.4: APAC Biobanking Market
    • 4.4.1: APAC Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.4.2: APAC Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications
  • 4.5: ROW Biobanking Market
    • 4.5.1: ROW Biobanking Market by Product & Service: Equipment, Consumables, Software, and Services
    • 4.5.2: ROW Biobanking Market by Application: Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biobanking Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Biobanking Market by Sample Type
    • 6.1.3: Growth Opportunities for the Global Biobanking Market by Application
    • 6.1.4: Growth Opportunities for the Global Biobanking Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Biobanking Market by Region
  • 6.2: Emerging Trends in the Global Biobanking Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biobanking Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: PHC Holdings
  • 7.3: Becton
  • 7.4: Dickinson and Company
  • 7.5: QIAGEN
  • 7.6: Greiner Holding
  • 7.7: Bay Biosciences